Financhill
Buy
84

GME Quote, Financials, Valuation and Earnings

Last price:
$28.54
Seasonality move :
0.42%
Day range:
$27.85 - $28.78
52-week range:
$17.70 - $48.00
Dividend yield:
0%
P/E ratio:
109.65x
P/S ratio:
2.94x
P/B ratio:
2.59x
Volume:
4.8M
Avg. volume:
8.1M
1-year change:
23.21%
Market cap:
$12.7B
Revenue:
$3.8B
EPS (TTM):
$0.26

Earnings Data

Next earnings date for GME
Jun 06
2025
Most recent earnings per share
$0.29
Beat by $0.21
(Mar 25/2025)
Consensus Estimate
$0.08
(Mar 25/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GME Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/31/2025 Q3 $748.2M -- -- $0.06 --
06/06/2025 Q2 $754.2M -- -- $0.04 --
03/25/2025 Q1 $1.5B $1.3B $0.29 $0.08 $0.21
12/10/2024 Q4 $887.7M $860.3M $0.04 -$0.03 $0.07
09/10/2024 Q3 $895.7M $798.3M $0.04 -$0.09 $0.13
06/07/2024 Q2 $995.3M $881.8M -$0.11 -$0.09 -$0.02
03/21/2024 Q1 $2B $1.8B $0.20 $0.30 -$0.10
12/06/2023 Q4 $1.2B $1.1B -$0.01 -$0.08 $0.07
09/06/2023 Q3 $1.1B $1.2B -$0.01 -$0.14 $0.13
06/07/2023 Q2 $1.4B $1.2B -$0.17 -$0.12 -$0.05
03/21/2023 Q1 -- $2.2B $0.16 -- --
12/07/2022 Q4 -- $1.2B -$0.31 -- --
09/07/2022 Q3 -- $1.1B -$0.36 -- --
06/01/2022 Q2 -- $1.4B -$0.52 -- --
03/17/2022 Q1 -- $2.3B -$0.49 -- --
12/08/2021 Q4 -- $1.3B -$0.35 -- --
09/08/2021 Q3 -- $1.2B -$0.21 -- --
06/09/2021 Q2 -- $1.3B -$0.25 -- --
03/23/2021 Q1 -- $2.1B $0.30 -- --
12/08/2020 Q4 -- $1B -$0.07 -- --
09/09/2020 Q3 -- $942M -$0.43 -- --
06/09/2020 Q2 -- $1B -$0.64 -- --
03/26/2020 Q1 -- $2.2B $0.08 -- --
12/10/2019 Q4 -- $1.4B -$0.26 -- --
09/10/2019 Q3 -- $1.3B -$1.04 -- --
06/04/2019 Q2 -- $1.5B $0.02 -- --
04/02/2019 Q1 -- $3.1B -$0.46 -- --
11/29/2018 Q4 -- $1.9B -$1.20 -- --
09/06/2018 Q3 -- $1.5B -$0.06 -- --
05/31/2018 Q2 -- $1.8B $0.07 -- --
03/28/2018 Q1 -- $2.8B -$0.26 -- --
11/21/2017 Q4 -- $2B $0.15 -- --
08/24/2017 Q3 -- $1.7B $0.06 -- --
05/25/2017 Q2 -- $2B $0.15 -- --
03/23/2017 Q1 -- $2.4B $0.51 -- --
11/22/2016 Q4 -- $2B $0.12 -- --
08/25/2016 Q3 -- $1.6B $0.07 -- --
05/26/2016 Q2 -- $2B $0.16 -- --
03/24/2016 Q1 -- $3.5B $0.59 -- --
11/23/2015 Q4 -- $2B $0.13 -- --
08/27/2015 Q3 -- $1.8B $0.06 -- --

GameStop Earnings Questions

  • How Much did GameStop Generate in Revenue Last Quarter?

    GameStop reported $1.3B worth of top line sales in its most recent quarter.

  • Did GameStop Beat Earnings Last Quarter?

    GameStop announced earnings per share of $0.29 which represents a beat of analyst forecast a $0.08 per share.

  • Is GameStop Profitable?

    GameStop reported $363.4M that represents $0.81 per share over the last quarter.

  • What is the Analyst Consensus for GameStop EPS Next Year?

    GameStop's earnings are forecast to grow from $0.33 per share to $0.07 per share next year representing an increase of 37.88%.

  • When is GameStop's Earnings Date?

    GameStop's next earnings date is June 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Is Dick’s Sporting Goods Buying Foot Locker Smart?
Is Dick’s Sporting Goods Buying Foot Locker Smart?

Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
55
RGC alert for May 21

Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.

Buy
64
AKRO alert for May 21

Akero Therapeutics [AKRO] is up 24.59% over the past day.

Buy
76
AGYS alert for May 21

Agilysys [AGYS] is up 22.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock